NCT05186753 2026-03-04(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisCogent Biosciences, Inc.Phase 2 Active not recruiting237 enrolled